argenx SE at Bank of America Global Healthcare Conference Transcript
Hello, and welcome back to the Bank of America Healthcare Conference. I'm Tazeen Ahmad, I'm one of the biotech analysts here at the bank. Our next presenting company is argenx. Sitting up here on stage with me is the new CEO, Karen Massey. Congratulations, Karen, on the recent promotion.
Questions & Answers
We're going to be spending time, I think, focused a little bit on the pipeline because there's a lot going on. But maybe we can start off by talking about what your vision is for the company now that you're helming, all the major decisions and how you think about strategy going forward.
Yeah. Thank you so much. It's great to be here and a great conference. So, and appreciate the opportunity. I mean, I would say we have laid out our growth strategy for argenx, and that's Vision 2030. And so that gets us to 50,000
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
